AstraZeneca and Serum Institute of India's COVID-19 Vaccine Receive WHO's EUA to Prevent COVID-19
Shots:
- WHO has granted EUL to AZ’s vaccine for active immunization to prevent COVID-19 in individuals aged ≥18yrs.- including those over 65yrs. EUL granted AZ and SII enabling global access to the vaccine
- The WHO’s SAGE recommended a dosing interval of 8-12wks. and also recommended the use of the vaccine in countries where new variants- including the South African B1.351 variant- are prevalent
- AZ & SII will work with the COVAX Facility to begin the supply of vaccine across the globe and will be allocated equitably according to the COVAX Allocation Framework
Ref: AstraZeneca | Image: Mint
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com